Invention Grant
- Patent Title: Human serum albumin in formulations
-
Application No.: US16807406Application Date: 2020-03-03
-
Publication No.: US11241499B2Publication Date: 2022-02-08
- Inventor: Dorothy Kim , Michael Marlow
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Kramer Levin Naftalis & Frankel LLP
- Main IPC: A61K47/42
- IPC: A61K47/42 ; A61K47/26

Abstract:
Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided.
Public/Granted literature
- US20200282063A1 Human Serum Albumin in Formulations Public/Granted day:2020-09-10
Information query
IPC分类: